-
Behavioral Medicine & Nephrology
A software platform to monitor and improve patients' adherence to medications and treatments.
-
Infection treatment and prevention (pre / probiotic)
Probiotic bacteria strains increase infection resistance.
-
Gastroenterology
Plasma Proteomic Response Signature of Children Receiving Infliximab for Crohn’s Disease
-
Drug Delivery
A prototype of a self-contained morcellator for preparing medication
for feeding tube delivery
-
Dermatology
A newly established link between the mechanistic role of thrombin and fibrinogen and their contribution to AD provides a novel mechanism for oral treatment.
-
Drug Discovery and Development
Comprehensive method to package mRNA gene therapies, vaccines
and protein replacement therapies
-
Gastroenterology
Oncostatin M biomarkers are associated with non-response to Infliximab therapy
-
Genetic Diseases
Optimal dosing regimen for treating seizures and self-aggressive behavior
-
Drug Discovery and Development
Single cell labeling method to aid in applied medicine and drug
development
-
Oncology
Our proprietary inhibitor binds to VAV3 thereby inhibiting the activation of RAC downstream of several oncogenes.